AI assistant
BOIRON — Interim / Quarterly Report 2015
Jul 17, 2015
1161_iss_2015-07-17_2e47285e-7fef-4b90-a105-fffb25718c45.pdf
Interim / Quarterly Report
Open in viewerOpens in your device viewer
2015 HALF-YEAR ACTIVITY
(Unaudited data)
• CUMULATIVE ACTIVITY AS OF THE END OF JUNE 2015
| 2014 | 2015 | Variation at | Variation at | |
|---|---|---|---|---|
| thousands of euros | current | constant | ||
| exchange rates | exchange rates | |||
| France | 157,018 | 166,448 | + 6.0% | + 6.0% |
| Europe (excluding France) | 73,537 | 70,600 | - 4.0% | - 2.6% |
| North America | 23,287 | 30,087 | + 29.2% | + 7.7% |
| Other countries | 7,774 | 8,438 | + 8.5% | + 9.7% |
| Group total | 261,616 | 275,573 | + 5.3% | + 3.9% |
| 2014 | 2015 | Variation at | Variation at | |
| thousands of euros | current | constant | ||
| exchange rates | exchange rates | |||
| Non-proprietary Homeopathic Medicines | 150,991 | 153,545 | + 1.7% | + 0.7% |
| OTC Specialties | 110,254 | 121,910 | + 10.6% | + 8.4% |
| Other | 371 | 118 | - 68.2% | - 43.9% |
| Group total | 261,616 | 275,573 | + 5.3% | + 3.9% |
• ACTIVITY IN THE QUARTER (variation at current rate)
| 1st Quarter | 2nd Quarter | |||||
|---|---|---|---|---|---|---|
| thousands of euros | 2014 | 2015 | Var. 15/14 |
2014 | 2015 | Var. 15/14 |
| France | 82,749 | 89,584 | +8.3% | 74,269 | 76,864 | +3.5% |
| Europe (excluding France) | 39,967 | 40,657 | +1.7% | 33,570 | 29,943 | -10.8% |
| North America | 12,662 | 17,193 | +35.8% | 10,625 | 12,894 | +21.4% |
| Other countries | 4,831 | 4,622 | -4.3% | 2,943 | 3,816 | +29.7% |
| Group total | 140,209 | 152,056 | +8.4% | 121,407 | 123,517 | +1.7% |
| 1st Quarter | 2nd Quarter | |||||
|---|---|---|---|---|---|---|
| thousands of euros | 2014 | 2015 | Var. | 2014 | 2015 | Var. |
| 15/14 | 15/14 | |||||
| Non-proprietary Homeopathic Medicines | 77,919 | 79,191 | +1.6% | 73,072 | 74,354 | +1.8% |
| OTC Specialties | 62,196 | 72,880 | +17.2% | 48,058 | 49,030 | +2.0% |
| Other | 94 | -15 | - | 277 | 133 | -52.0% |
| Group total | 140,209 | 152,056 | +8.4% | 121,407 | 123,517 | +1.7% |
HIGHLIGHTS OF THE SECOND QUARTER 2015
Sales in the second quarter of 2015 rose by 1.7% compared to the second quarter of 2014: business activity increased in France and the US and decreased, especially, in Russia, Spain and Poland.
Profitability in the first half of 2015 should rise compared to 2014.
BOIRON will continue its involvement in the development of homeopathy with confidence and ambition. Taking into account the geopolitical risks, especially in Russia, the BOIRON group remains cautious in its outlook for 2015.
Our next update:
Person responsible for financial information: Christian Boiron
Contact for financial information: Véronique Bouscayrol
Investor relations: +33 (0) 4.78.45.63.43 - e-mail : [email protected]
ISIN Code: FR0000061129 (BOI) - Bloomberg : BOI FP - Reuters : BOIR.PA
The group's financial information is online at: www.boironfinance.com
September 3, 2015: at market close, publication of 2015 half-year results.